These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17217378)

  • 21. Molecular alterations in prostate carcinomas that associate with in vivo exposure to chemotherapy: identification of a cytoprotective mechanism involving growth differentiation factor 15.
    Huang CY; Beer TM; Higano CS; True LD; Vessella R; Lange PH; Garzotto M; Nelson PS
    Clin Cancer Res; 2007 Oct; 13(19):5825-33. PubMed ID: 17908975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen-independent prostate cancer.
    Narita S; So A; Ettinger S; Hayashi N; Muramaki M; Fazli L; Kim Y; Gleave ME
    Clin Cancer Res; 2008 Sep; 14(18):5769-77. PubMed ID: 18794086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue.
    Walton TJ; Li G; McCulloch TA; Seth R; Powe DG; Bishop MC; Rees RC
    Prostate; 2009 Jun; 69(8):810-9. PubMed ID: 19189301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer.
    Koike H; Sekine Y; Kamiya M; Nakazato H; Suzuki K
    Urology; 2008 Dec; 72(6):1229-33. PubMed ID: 18336887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer.
    Davies G; Ablin RJ; Mason MD; Jiang WG
    J Exp Ther Oncol; 2007; 6(3):257-64. PubMed ID: 17552366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
    Das S; Roth CP; Wasson LM; Vishwanatha JK
    Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression analysis and clinical utility of L-Dopa decarboxylase (DDC) in prostate cancer.
    Avgeris M; Koutalellis G; Fragoulis EG; Scorilas A
    Clin Biochem; 2008 Oct; 41(14-15):1140-9. PubMed ID: 18586020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms.
    Dong Y; Bui LT; Odorico DM; Tan OL; Myers SA; Samaratunga H; Gardiner RA; Clements JA
    Endocr Relat Cancer; 2005 Dec; 12(4):875-89. PubMed ID: 16322328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate cancer overexpresses CD44 variants 7-9 at the messenger RNA and protein level.
    Iczkowski KA; Bai S; Pantazis CG
    Anticancer Res; 2003; 23(4):3129-40. PubMed ID: 12926045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications.
    Wang JC; Bégin LR; Bérubé NG; Chevalier S; Aprikian AG; Gourdeau H; Chevrette M
    Clin Cancer Res; 2007 Apr; 13(8):2354-61. PubMed ID: 17406028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis.
    Antunes AA; Leite KR; Sousa-Canavez JM; Camara-Lopes LH; Srougi M
    J Urol; 2009 Feb; 181(2):594-600. PubMed ID: 19084862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type IV collagenase (M(r) 72,000) expression in human prostate: benign and malignant tissue.
    Stearns ME; Wang M
    Cancer Res; 1993 Feb; 53(4):878-83. PubMed ID: 7679051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression profiling reveals overexpression of TSPAN13 in prostate cancer.
    Arencibia JM; Martín S; Pérez-Rodríguez FJ; Bonnin A
    Int J Oncol; 2009 Feb; 34(2):457-63. PubMed ID: 19148481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of decreased Galectin-3 expression in the pathogenesis and progression of prostate cancer.
    Merseburger AS; Kramer MW; Hennenlotter J; Simon P; Knapp J; Hartmann JT; Stenzl A; Serth J; Kuczyk MA
    Prostate; 2008 Jan; 68(1):72-7. PubMed ID: 18008332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor binding protein-3 (IGFBP-3) in the prostate and in prostate cancer: local production, distribution and secretion pattern indicate a role in stromal-epithelial interaction.
    Massoner P; Haag P; Seifarth C; Jurgeit A; Rogatsch H; Doppler W; Bartsch G; Klocker H
    Prostate; 2008 Aug; 68(11):1165-78. PubMed ID: 18459102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.
    Zhigang Z; Wenlu S
    Prostate; 2008 Feb; 68(2):190-9. PubMed ID: 18076024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of interleukin-8 expression in human prostate cancer cells by insulin-like growth factor-I and inflammatory cytokines.
    Kooijman R; Himpe E; Potikanond S; Coppens A
    Growth Horm IGF Res; 2007 Oct; 17(5):383-91. PubMed ID: 17513150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MUC1 expression in human prostate cancer cell lines and primary tumors.
    O'Connor JC; Julian J; Lim SD; Carson DD
    Prostate Cancer Prostatic Dis; 2005; 8(1):36-44. PubMed ID: 15477874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA microarray analysis reveals metastasis-associated genes in rat prostate cancer cell lines.
    Reyes I; Tiwari R; Geliebter J; Reyes N
    Biomedica; 2007 Jun; 27(2):190-203. PubMed ID: 17713630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. cDNA microarray analysis of pigment epithelium-derived factor-regulated gene expression profile in prostate carcinoma cells.
    Liu W; Wu Z; Guan M; Lu Y
    Int J Urol; 2009 Mar; 16(3):323-8. PubMed ID: 19207613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.